ClinicalTrials.gov
ClinicalTrials.gov Menu

Alemtuzumab to Treat Severe Aplastic Anemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00195624
Recruitment Status : Active, not recruiting
First Posted : September 19, 2005
Last Update Posted : April 23, 2018
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 31, 2018
  Estimated Study Completion Date : December 31, 2020
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):